Clinical Trials
8 trialsNCT07586215 2026-05-14
PREDICT-HER
Fudan University
Recruiting
NCT06750484 2026-05-06
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
Yale University
Phase 2 Recruiting
NCT06706570 2026-03-24
PIK3CA Mutational Status Assessment
European Institute of Oncology
Recruiting
NCT06849947 2025-12-24
Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer
Samsung Medical Center
Phase 2 Not yet recruiting
NCT04603183 2025-12-12
ABIGAIL
MedSIR
Phase 2 Completed
NCT06616987 2025-08-28
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer
Samsung Medical Center
Phase 2 Recruiting
NCT06876636 2025-07-29
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
Xijing Hospital
Phase NA Active not recruiting
NCT06914661 2025-07-08
EASOFDIMBCT
The First Hospital of Jilin University
Enrolling by invitation